SHIFTBIO developed diverse outstanding
platform technologies based on nanovesicle .

Development of Nanovesicle Platform Technology to solve unmet medical needs

SHIFTBIO developed diverse
oustanding platform technologies
based on exosome.

Development of Exosome Platform Technology to solve unmet medical needs

Fusosome platform technology
that can specifically
fuse to the surface of cancer cells

Fusosome is a platform technology
that facilitates membrane-editing and 
direct delivering therapeutic cargos
into the cancer cell cytoplasm.

Fusosome is a platform technology that facilitates membrane-editing
and 
direct delivering therapeutic cargos into the cancer cell cytoplasm.